Seller record · Telehealth service

Wellorithm

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. The NAD+ page says only that the product is compounded by state-licensed pharmacies, and the terms and the privacy policy name none. 1 more criterion also fails; see the table below.

At a glance

WellorithmTelehealth service

6/8criteria passed
Price
Wegovy $899 a month; sermorelin $150 first month, then $200
Sells
brand Ozempic and Wegovy, brand Mounjaro and Zepbound, and 3 more
FDA letters
None on file
Visit WellorithmSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Miami telehealth service selling brand GLP-1 pens by monthly price, alongside compounded sermorelin and NAD+ injections with first-month prices that rise after. It names its physicians but no pharmacy and no legal entity.

Operating entity No legal entity name appears in the footer, on the contact page, in the terms or in the privacy policy; the terms describe Wellorithm only as a Miami-based company.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSWellorithm's website; Wellorithm's ozempic page
S2Prescription gatingPASSWellorithm's quiz 2 page; Wellorithm's sermorelin quiz page
S3Pharmacy identificationFAILWellorithm's NAD+ page; Wellorithm's terms conditions; Wellorithm's privacy policy
S4Compounding disclosurePASSWellorithm's sermorelin page; Wellorithm's NAD+ page
S5Analytical documentationFAILWellorithm's sermorelin page; Wellorithm's NAD+ page; Wellorithm's FAQ
S6Business addressPASSWellorithm's contact us page
S7Price disclosurePASSWellorithm's wegovy page; Wellorithm's ozempic page; Wellorithm's zepbound page; Wellorithm's mounjaro page; Wellorithm's sermorelin page; Wellorithm's NAD+ page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed clinician reviews each health assessment and recommends treatment only when medically appropriate, and the product pages name the partner physicians.Source: Wellorithm's website; Wellorithm's ozempic page.
S2PASSThe qualify button opens a health quiz whose first screen asks the buyer's weight loss goal, and the sermorelin path opens on an eligibility question.Source: Wellorithm's quiz 2 page; Wellorithm's sermorelin quiz page.
S3FAILThe site names no filling pharmacy. The NAD+ page says only that the product is compounded by state-licensed pharmacies, and the terms and the privacy policy name none.Source: Wellorithm's NAD+ page; Wellorithm's terms conditions; Wellorithm's privacy policy.
S4PASSThe sermorelin and NAD+ pages state that compounded medications are not reviewed or approved by the FDA for safety or effectiveness, and the NAD+ page says the product is not FDA-approved.Source: Wellorithm's sermorelin page; Wellorithm's NAD+ page.
S5FAILNo certificate of analysis or lot document is published on the product pages, the FAQ or the terms.Source: Wellorithm's sermorelin page; Wellorithm's NAD+ page; Wellorithm's FAQ.
S6PASSWellorithm at 7931 NW 68th Street, Miami, FL 33166, printed on the contact page. No legal entity name is printed beside it.Source: Wellorithm's contact us page.
S7PASSBrand Wegovy at $899 a month, Ozempic and Zepbound at $1,199 a month and Mounjaro at $1,399 a month, with a discount of up to $100 on the first order applied at checkout. Sermorelin and NAD+ injections at $150 for the first month, then $200 a month.Source: Wellorithm's wegovy page; Wellorithm's ozempic page; Wellorithm's zepbound page; Wellorithm's mounjaro page; Wellorithm's sermorelin page; Wellorithm's NAD+ page.
S8PASSNo FDA warning letter names Wellorithm, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: brand Ozempic and Wegovy, brand Mounjaro and Zepbound, sermorelin injection, NAD+ injection, tadalafil.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+

Visit Wellorithm

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.